$0.05
(Market cap
$143 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
2.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-0.5 %
-
ROCE
-- %
-
Industry P/E
29.94
-
EV/EBITDA
0.1
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-0.3
-
Face value
--
-
Shares outstanding
63,226,556
7 Years Aggregate
CFO
$-118.49 Mln
EBITDA
$-132.90 Mln
Net Profit
$-230.88 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Equillium (EQ)
| 45.8 | 5.1 | 29.9 | 486.9 | 53.8 | -18.6 | -- |
|
BSE Sensex*
| -9.7 | -0.2 | -7.0 | -6.4 | 7.4 | 8.6 | 11.7 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Equillium (EQ)
| 107.2 | 3.9 | -32.1 | -71.9 | -29.5 | 58.3 | -58.6 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Equillium (EQ)
|
2.3 | 142.9 | 0.0 | -19.1 | -- | -42.1 | -- | 2.4 |
| 41.0 | 5,252.7 | 1,105.3 | 133.3 | 15.9 | 32.7 | 38.3 | 12.7 | |
| 236.0 | 12,143.0 | 708.2 | -188.3 | -25.6 | -293.5 | -- | 222.5 | |
| 69.1 | 13,537.9 | 580.0 | -725.9 | -105.2 | -- | -- | 123.7 | |
| 31.3 | 3,825.6 | 597.0 | 221.3 | 46.1 | 22.9 | 18.1 | 3.8 | |
| 60.2 | 6,464.7 | 769.1 | 47.9 | 5.4 | 7.5 | 172.1 | 10.0 | |
| 21.7 | 10,413.5 | 4,893.0 | -242.0 | -1.5 | -3.7 | -- | 1.5 | |
| 8.0 | 5,431.0 | 7,447.6 | 415.6 | 16.2 | 6.6 | 11.2 | 0.9 | |
| 229.3 | 4,596.0 | 274.5 | 153.6 | 76.6 | 15.8 | 29.9 | 4.6 | |
| 61.0 | 5,422.8 | 288.1 | 22.3 | 17.5 | 34.1 | 358.7 | 49.9 |
Shareholding Pattern
View DetailsAbout Equillium (EQ)
Equillium, Inc., a clinical-stage biotechnology company, develops therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders in the United States. The company develops EQ504, a novel AhR modulator that is in... preclinical-stage for the treatment of ulcerative colitis and lung inflammation diseases. It also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc. in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California. Read more
-
Executive Chairman
Mr. Daniel Mark Bradbury
-
Executive Chairman
Mr. Daniel Mark Bradbury
-
Headquarters
La Jolla, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Equillium (EQ)
What is the current share price of Equillium Inc (EQ) Today?
The share price of Equillium Inc (EQ) is $2.26 (NASDAQ) as of 22-May-2026 16:00 EDT. Equillium Inc (EQ) has given a return of 53.78% in the last 3 years.
What is the current PB & PE ratio of Equillium Inc (EQ)?
Since, TTM earnings of Equillium Inc (EQ) is negative, P/E ratio is not available.
The P/B ratio of Equillium Inc (EQ) is 2.40 times as on 22-May-2026, a 60 discount to its peers’ median range of 6.06 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-3.94
|
3.09
|
|
2024
|
-3.25
|
1.37
|
|
2023
|
-1.89
|
1.12
|
|
2022
|
-0.58
|
1.13
|
|
2021
|
-2.80
|
1.64
|
What is the 52 Week High and Low of Equillium Inc (EQ)?
The 52-week high and low of Equillium Inc (EQ) are Rs 2.70 and Rs 0.27 as of 25-May-2026.
What is the market cap of Equillium Inc (EQ)?
Equillium Inc (EQ) has a market capitalisation of $ 143 Mln as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Equillium Inc (EQ)?
Before investing in Equillium Inc (EQ), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.